Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI109889

Effect of Thyroid Status on Insulin Action in Rat Adipocytes and Skeletal Muscle

Michael P. Czech, Craig C. Malbon, Keith Kerman, Wendy Gitomer, and Paul F. Pilch

Section of Physiological Chemistry, Division of Biology and Medicine, Brown University, Providence, Rhode Island 02912

Find articles by Czech, M. in: PubMed | Google Scholar

Section of Physiological Chemistry, Division of Biology and Medicine, Brown University, Providence, Rhode Island 02912

Find articles by Malbon, C. in: PubMed | Google Scholar

Section of Physiological Chemistry, Division of Biology and Medicine, Brown University, Providence, Rhode Island 02912

Find articles by Kerman, K. in: PubMed | Google Scholar

Section of Physiological Chemistry, Division of Biology and Medicine, Brown University, Providence, Rhode Island 02912

Find articles by Gitomer, W. in: PubMed | Google Scholar

Section of Physiological Chemistry, Division of Biology and Medicine, Brown University, Providence, Rhode Island 02912

Find articles by Pilch, P. in: PubMed | Google Scholar

Published September 1, 1980 - More info

Published in Volume 66, Issue 3 on September 1, 1980
J Clin Invest. 1980;66(3):574–582. https://doi.org/10.1172/JCI109889.
© 1980 The American Society for Clinical Investigation
Published September 1, 1980 - Version history
View PDF
Abstract

Isolated adipocytes and soleus muscles prepared from mature rats, rendered hypothyroid by a low iodine diet and propylthiouracil, markedly resisted the ability of insulin to increase glucose utilization. In adipocytes, the sum of basal d-(1-14C)-glucose conversion to CO2, glyceride-glycerol, and fatty acid was unaltered by hypothyroidism, although conversion to fatty acid was decreased. The response of each of these metabolic pathways to insulin at all concentrations tested was greatly diminished in hypothyroid rat adipocytes. 3-O-Methylglucose transport rates in the presence of insulin were not significantly different in adipocytes from hypothyroid as compared with euthyroid rats, although basal transport rates were significantly higher in the hypothyroid state. Lipolysis and cyclic AMP accumulation in adipocytes from hypothyroid rats in response to theophylline were markedly diminished compared with euthyroid controls, but insulin was about as effective in inhibiting lipolysis in these cells as in those derived from euthyroid animals. The binding of 125I-insulin to adipocytes at several hormone concentrations was also shown to be unaffected by hypothyroidism.

In soleus muscle, basal glucose conversion to H2O and glycogen was unaltered in the hypothyroid state, whereas insulin action on these pathways was markedly inhibited. The decrease in muscle insulin responsiveness was less marked than that observed in adipocytes. Uptake of either 2-deoxyglucose or l-arabinose in the presence or absence of insulin was similar in soleus muscles derived from euthryoid vs. hypothyroid rats. Similarly, insulin action on the conversion of soleus muscle glycogen synthase D to the I form in the absence of glucose was unaltered by hypothyroidism. We conclude that (a) hypothyroidism in mature rats leads to a marked decrease in the responsiveness of glucose metabolism in adipocytes and skeletal muscle to insulin; (b) no detectable impairment of the membrane insulin effector systems that mediate the regulation of adipocyte hexose transport and glycogen synthase is caused by hypothyroidism in this animal model; and (c) the cellular defect that leads to apparent insulin resistance of adipocyte and soleus muscle glucose utilization resides at the level of one or more intracellular enzymes involved in glucose catabolism.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 574
page 574
icon of scanned page 575
page 575
icon of scanned page 576
page 576
icon of scanned page 577
page 577
icon of scanned page 578
page 578
icon of scanned page 579
page 579
icon of scanned page 580
page 580
icon of scanned page 581
page 581
icon of scanned page 582
page 582
Version history
  • Version 1 (September 1, 1980): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts